University at Albany, State University of New York
Contact UAlbany Directories Calendars & Schedules Visitors Site Index Search
Admissions Academics Research IT Services Libraries Athletics
Prospective Students
Current Students and Parents
Alumni
Faculty and Staff
My UAlbany
About the University
News
Outreach
Support UAlbany
Employment

 

  time line:

 •

Gen*NY*Sis Center for Excellence in Cancer Genomics enacted: 2001

 

 •

Grant Awarded: September 19, 2002

 

 •

Groundbreaking:
June 24, 2003

 

 •

Center Opening:
2005

Feature
 

The UAlbany Gen*NY*Sis Center: Dedicated to Excellence in Cancer Research

Rendering of the UAlbany Gen*NY*Sis Center for Excellence in Cancer Genomics

 

Rendering of the UAlbany Gen*NY*Sis Center for Excellence in Cancer Genomics

The UAlbany Gen*NY*Sis Center for Excellence in Cancer Genomics is committed to research that will lead to finding a cure for cancer. Located on the University at Albany Foundation’s East Campus in Rensselaer, the new Center will combine UAlbany research expertise in genomics and biomedical sciences with state-of-the-art technology in a new 113,000 square foot building. The Center is a $45 million project which was launched with a $22.5 million grant from New York State's Gen*NY*Sis Program. Additional funds will be secured through individual, corporate, and foundation gifts.

Rendering of the Wall of Memory and Hope

 

Rendering of the Center's Wall of Memory and Hope

 
 

The initial fundraising goal of the Center’s campaign is $25 million to equip the facility and support the cutting-edge research. Senator Joseph L. Bruno is the Honorary Chair of the campaign, which is called “The Fund for Memory and Hope.” A centerpiece of the Center’s new entrance lobby will be the Wall of Memory and Hope which will display dedicated plaques chosen by donors to the Gen*NY*Sis Center for Excellence in Cancer Genomics.

Looking toward achieving the long term goal of building a Comprehensive Cancer Center – a designation awarded by the National Cancer Institute, the Center will undertake this cutting-edge cancer research in partnership with a number of regional institutions and companies, such as the University at Albany’s School of Public Health, Albany Medical Center, Taconic Biotechnology, Inc., General Electric and the University at Albany’s Center for Functional Genomics, under the directorship of Dr. Paulette McCormick. She has dedicated her career to understanding and finding a cure for the disease. “The new building, located on the University at Albany Foundation’s East Campus will stand as a symbol of hope for all those afflicted with cancer,” says Dr. McCormick.

To see more about Gen*NY*Sis Center for Excellence in Cancer Genomics visit, www.albany.edu/cancergenomics
Or contact:
Dr. Paulette McCormick, Director
The Gen*NY*Sis Center for Excellence in Cancer Genomics
(518) 591-8300
genomics@albany.edu

Related Links:
School of Public Health
Center for Functional Genomics
University at Albany Foundation’s East Campus


Tell Us Your Story

 

 

Meet the scientists who are breaking the gene barrier and learn more about their research:

Click for larger image; l-r: Chittibabu Guda, Igor Kuznetsov, Scott Tenenbaum, Paulette McCormick, Julio Aguirre-Ghiso, Thomas Begley and Doug Conklin

From left to right:

Dr. Chittibabu Guda is developing bioinformatics tools and databases including reconstruction of pathways associated with cancer and other diseases.

Dr. Igor Kuznetsov is using bioinformatics methods to study the mechanisms of conformational flexibility in proteins and gene regulation, including the role of these mechanisms in the development of cancer and other human diseases.

Dr. Scott Tenenbaum is a pioneer in the study of ribonomics, which provides a broad picture of gene function that may help explain why similar tumors respond differently to the same treatment and may lead to better “customized” treatments.

Dr. Paulette McCormick is dedicated to studying the genetics of cancer biology and tumor growth with a particular emphasis on how an individual's genetic make-up should guide their cancer treatment.

Dr. Julio Aguirre-Ghiso studies the molecular-genetic mechanisms that cause head & neck, breast, prostate and melanoma tumors to spread and grow (metastasize) and is investigating new therapies to halt their growth by inducing dormancy.

Dr. Thomas Begley focuses on cellular responses to chemotherapeutic medicines and mechanisms of resistance by cancer cells.

Dr. Douglas Conklin is a key contributor in the development of a new technique called RNA interference which he is using to identify genes required for cancer cell growth and aggressiveness in a variety of tumor types.

Dr. Richard Cunningham (not pictured) is studying the way in which cells repair DNA when it is damaged, potentially leading to new ways to enhance the effectiveness of cancer-killing therapies.

To learn more about the work of these researchers >>

 
 
     Recent Features:
 

Feature Archives  |  News & Information  |  Top
 


University at Albany Home Page

Contact UAlbany | Directories | Calendars | Visitors | Site Index | Search
Admissions | Academics | Research | IT Services | Libraries | Athletics